ArticleMolecular and clinical oncology2018
Lung cancer patients with synchronous colon cancer.
Article in Molecular and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Successful Treatment of Synchronous Double Lung and Colon Cancers Using Immune Checkpoint Inhibitors.Internal medicine (Tokyo, Japan) · 2026Article
- A Hybrid Lung and Colon Histopathological Image Classification Framework Using MobileNetV3-Small Deep Features and Differential Evolution Optimization.Diagnostics (Basel, Switzerland) · 2026Article
- Dual-Path Convolutional Neural Network with Squeeze-and-Excitation Attention for Lung and Colon Histopathology Classification.Journal of imaging · 2025Article
- Cytoskeleton imaging of colorectal and lung cancer spheroids using light sheet microscopy.BJC reports · 2025Article
- Article
- A feature engineering-based machine learning technique to detect and classify lung and colon cancer from histopathological images.Medical & biological engineering & computing · 2024Article
- Spatial Difference Boundary Detection for Multiple Outcomes Using Bayesian Disease Mapping.Biostatistics (Oxford, England) · 2023Article
- Paraneoplastic Polyarthritis in a Patient with Synchronous Lung and Colorectal Malignancy.Mediterranean journal of rheumatology · 2023Article
- A Novel Heteromorphous Convolutional Neural Network for Automated Assessment of Tumors in Colon and Lung Histopathology Images.Biomimetics (Basel, Switzerland) · 2023Article
- An Explainable Classification Method Based on Complex Scaling in Histopathology Images for Lung and Colon Cancer.Diagnostics (Basel, Switzerland) · 2023Article
- Histopathological Analysis for Detecting Lung and Colon Cancer Malignancies Using Hybrid Systems with Fused Features.Bioengineering (Basel, Switzerland) · 2023Article
- A Framework for Lung and Colon Cancer Diagnosis via Lightweight Deep Learning Models and Transformation Methods.Diagnostics (Basel, Switzerland) · 2022Article
- Hierarchical multivariate directed acyclic graph autoregressive models for spatial diseases mapping.Statistics in medicine · 2022Article
- Chitin and Chitosan: Prospective Biomedical Applications in Drug Delivery, Cancer Treatment, and Wound Healing.Marine drugs · 2022Review
- KRAS G12C-Mutant Non-Small-Cell Lung Adenocarcinoma: First Documented Report in the Arabian Gulf.Cureus · 2022Article
- Article
- High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract Radiotherapy.Gastro hep advances · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung and colon cancers are two of the most common malignancies, which, in some cases, may develop synchronously. In the present study, the treatment and outcome of patients with synchronous lung and colon cancers were reviewed. During a 76-month study period, from April 2009 up to July 2016, 17 (0.54%) of 3,102 patients with lung cancer were diagnosed with colon cancer within 1 month. Heavy smoking and obesity were not specific factors in these patients. A total of 9 patients succumbed to lung cancer during the study period. Survival in asymptomatic patients was longer compared with that in symptomatic patients (median survival, 80 vs. 23.2 months, respectively; P=0.007). Although the incidence of synchronous occurrence of these two cancers may be low, particularly in patients diagnosed incidentally, such patients should be treated accordingly. Future genetic and epidemiological studies are required to elucidate the potential connection between lung and colon cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.